A phase 1 trial in Nature Medicine finds a personalised NeoVax vaccine plus nivolumab feasible in platinum-sensitive ovarian cancer, with acceptable safety.
Disclaimer: We provide paid authorship to contributors and do not monitor all content daily. As the owner, I do not promote or endorse illegal services such as betting, gambling, casino, or CBD.
